Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has urged shareholders to support change by voting for their nominated directors-John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters-at the upcoming shareholder meeting. Apollo Capital, which owns approximately 3.0% of the company's common stock, expressed concerns over MediPharm's financial health, warning that the company may run out of money by November 2025. They have advised shareholders to disregard any "GREEN" proxy cards from the current management and instead support their call for board-level change to address the company's declining financial position. Shareholders are encouraged to read the detailed circular available on SEDAR+ for more information.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。